These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 4504181)

  • 1. Hodgkin's disease: eleven years' experience at West Virginia University.
    Blum D; Harley JB; Krall JM
    W V Med J; 1972 Jul; 68(7):184-6. PubMed ID: 4504181
    [No Abstract]   [Full Text] [Related]  

  • 2. Hodgkin's disease: ten years' experience of a combined lymphoma clinic. The Prince of Wales Hospital Oncology Cooperative Group (lymphoma), Sidney.
    Med J Aust; 1980 Feb; 1(3):118-21. PubMed ID: 7374519
    [No Abstract]   [Full Text] [Related]  

  • 3. [The importance of nonspecific immunotherapy in Hodgkin's disease. Experience of the first comprehensive control team in the Department of General Medicine at Charles University in Prague].
    Dienstbier Z; Foltýnová V; Citavý M
    Cas Lek Cesk; 1986 Apr; 125(17):518-23. PubMed ID: 3521864
    [No Abstract]   [Full Text] [Related]  

  • 4. The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects.
    Donaldson SS; Hancock SL; Hoppe RT
    Cancer J Sci Am; 1999; 5(6):325-33. PubMed ID: 10606471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
    Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
    Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infradiaphragmatic Hodgkin's disease.
    Illés A; Vadász G; Bányai A; Szegedi G
    Haematologia (Budap); 1997; 28(3):117-22. PubMed ID: 9283911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hodgkin's and non-Hodgkin's lymphomas.
    McElwain TJ
    Br J Hosp Med; 1984 Jan; 31(1):10-4, 18-9. PubMed ID: 6697038
    [No Abstract]   [Full Text] [Related]  

  • 8. Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma.
    Dann EJ; Daugherty CK; Larson RA
    Bone Marrow Transplant; 1997 Sep; 20(5):369-74. PubMed ID: 9339751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Hodgkin's disease at a local hospital.
    Aghai E; Quitt M; Kuten A; Froom P
    Isr J Med Sci; 1995; 31(2-3):176-8. PubMed ID: 7744590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hodgkin's disease in a community oncology center: ten years' experience.
    Beck TM; Montgomery P; Smith CE
    West J Med; 1982 May; 136(5):384-9. PubMed ID: 7101905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of autologous stem cell transplantation for Hodgkin's disease (HD) and low-/intermediate-grade B non-Hodgkin's lymphoma (NHL): a report from the Austrian Stem Cell Transplantation Registry (ASCTR).
    Nachbaur D; Greinix HT; Koller E; Krieger O; Linkesch W; Kasparu H; Pober M; Hinterberger W; Hausmaninger H; Heistinger M; Ulsperger E; Karlhuber S; Schwinger W; Lindner B
    Ann Hematol; 2005 Jul; 84(7):462-73. PubMed ID: 15726362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.
    Wheeler C; Eickhoff C; Elias A; Ibrahim J; Ayash L; McCauley M; Mauch P; Schwartz G; Eder JP; Mazanet R; Ferrara J; Rimm IJ; Guinan E; Bierer B; Gilliland G; Churchill WH; Ault K; Parsons S; Antman K; Schnipper L; Tepler I; Gaynes L; Frei E; Kadin M; Antin J
    Biol Blood Marrow Transplant; 1997 Jun; 3(2):98-106. PubMed ID: 9267670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and relapse data in Hodgkin's disease: Freiburg im Breisgau, 1948-69.
    Musshoff K
    Natl Cancer Inst Monogr; 1973 May; 36():531-9. PubMed ID: 4744608
    [No Abstract]   [Full Text] [Related]  

  • 15. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).
    Lazarus HM; Loberiza FR; Zhang MJ; Armitage JO; Ballen KK; Bashey A; Bolwell BJ; Burns LJ; Freytes CO; Gale RP; Gibson J; Herzig RH; LeMaistre CF; Marks D; Mason J; Miller AM; Milone GA; Pavlovsky S; Reece DE; Rizzo JD; van Besien K; Vose JM; Horowitz MM
    Bone Marrow Transplant; 2001 Feb; 27(4):387-96. PubMed ID: 11313668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's lymphoma: a single center experience.
    Sperotto A; Zaja F; Damiani D; Patriarca F; Fanin R
    Haematologica; 2001 Dec; 86(12):1317-8. PubMed ID: 11726327
    [No Abstract]   [Full Text] [Related]  

  • 17. Late relapse after treatment for clinical stage I and II Hodgkin's disease.
    Brierley JD; Rathmell AJ; Gospodarowicz MK; Sutcliffe SB; Pintillie M
    Cancer; 1997 Apr; 79(7):1422-7. PubMed ID: 9083165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Laparotomy and splenectomy in Hodgkin's disease].
    Nikkanen V; Ojala A; Linna MI
    Duodecim; 1974; 90(3):178-85. PubMed ID: 4849043
    [No Abstract]   [Full Text] [Related]  

  • 19. [25 years of the German Study Group of Hodgkin's Disease--a successful cooperation of pathologists and clinicians].
    Diehl V; von Wasielewski R
    Verh Dtsch Ges Pathol; 2003; 87():58-65. PubMed ID: 16888895
    [No Abstract]   [Full Text] [Related]  

  • 20. Hodgkin's lymphoma: the hazards of success.
    Connors JM
    J Clin Oncol; 2003 Sep; 21(18):3388-90. PubMed ID: 12900526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.